5-hydroxytryptophan has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobsen, JPR | 1 |
| Krystal, AD | 1 |
| Krishnan, KRR | 1 |
| Caron, MG | 1 |
1 review available for 5-hydroxytryptophan and Depressive Disorder, Treatment-Resistant
| Article | Year |
|---|---|
Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents, Second-Generation; Delayed-Action Preparations; | 2016 |